A case of licensing mega deal : Sanofi – Hanmi Pharmaceutical for the development of investigational diabetes medicines
Posted on06 Nov 2015
TagsA case of pharma licensing mega deal, drug licensing, efpeglenatide, Globalpharma sanofi, GLP-1 Receptor Agonists, GLP1-agnostics, Hanmi Pharmaceutical, inlicensing in pharma, Sanofi, Sanofi - Hanmi Pharmaceutical for the development of investigational diabetes medicines
Comments0
South Korean pharmaceutical company Hanmi Pharmaceutical Co. said Thursday that it has reached a license agreement with global drugmaker Sanofi to develop... Read More